Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparative Effects of Post-exercise Ingestion of a High or Low Molecular Weight Solution on Resistance Exercise Performance

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02778373
Recruitment Status : Completed
First Posted : May 19, 2016
Last Update Posted : May 19, 2016
Sponsor:
Information provided by (Responsible Party):
Texas Christian University

Brief Summary:
This study sought to examine differences in resistance exercise performance, as measured by the kinetic and kinematic profile during multiple sets of the back squat exercise, following ingestion of high or low molecular weight carbohydrate beverages.

Condition or disease Intervention/treatment Phase
Task Performance and Analysis Dietary Supplement: Vitargo ®, Swecarb AB, Karlskrona, Sweden Dietary Supplement: DE15 maltodextrin, Matrin® M160, Grain Processing Corporation, Muscatine, IA Other: Placebo: Water Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 30 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Official Title: Comparative Effects of Post-exercise Ingestion of a High or Low Molecular Weight Solution on Resistance Exercise Performance
Study Start Date : September 2014
Actual Primary Completion Date : June 2015
Actual Study Completion Date : June 2015

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Placebo Comparator: Placebo
Flavored Water
Other: Placebo: Water
Active Comparator: Low Molecular Weight Carbohydrate
low molecular weight carbohydrate delivered post-endurance exercise in a 10% solution providing 1.2 grams/kg body weight carbohydrate
Dietary Supplement: DE15 maltodextrin, Matrin® M160, Grain Processing Corporation, Muscatine, IA
Experimental: High molecular weight carbohydrate
high molecular weight carbohydrate delivered post-endurance exercise in a 10% solution providing 1.2 grams/kg body weight carbohydrate
Dietary Supplement: Vitargo ®, Swecarb AB, Karlskrona, Sweden



Primary Outcome Measures :
  1. Change in Power Output [ Time Frame: 1 year ]
    Change in power output, measured in watts, will be examined over the course of the performance of 5 sets of 10 repetitions of the back squat exercise with a weight corresponding to 75% one-repetition maximum.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 35 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • having at least 2 years resistance training experience to include the parallel back squat exercise at least once a week
  • no musculoskeletal injury within previous 1 year
  • not having consumed any nutritional or ergogenic supplement excluding protein and/or a daily vitamin for the previous 6-week period

Exclusion Criteria:

  • no previous resistance training experience
  • musculoskeletal injury within the previous 1 year
  • having consumed or presenting consuming a nutritional or ergogenic supplement

Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Texas Christian University
ClinicalTrials.gov Identifier: NCT02778373     History of Changes
Other Study ID Numbers: 1401-45-1401
First Posted: May 19, 2016    Key Record Dates
Last Update Posted: May 19, 2016
Last Verified: May 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Additional relevant MeSH terms:
Layout table for MeSH terms
Pharmaceutical Solutions